This course will examine new findings pertaining to the diagnosis and management of central serious chorioretinopathy (CSCR) and what they mean for the practicing optometrist.  Key findings from recent studies will be discussed in order to provide an update on the etiology, manifestations, and pathophysiology of this condition.  We will also discuss the role of newer technologies such as enhanced depth imaging and OCT angiography on diagnosis.  Lastly, novel treatment options, including mineralocorticoid antagonist medications and subthreshold micropulse laser, will be assessed and incorporated into a current evidence-based management plan for various presentations of CSCR.

Course Code:



James Rogala, O.D.



AOA Expiration Date:


Related News

Doctors of optometry challenge reasoning behind proposed Eyeglass Rule changes at FTC workshop

The recent workshop heard testimony from various stakeholders on the potential impact that proposed changes to the Eyeglass Rule might have on consumer choice and the burden on the practices of doctors of optometry and ophthalmology, which are already understaffed and saddled with other federal regulation. The Federal Trade Commission will use the feedback to determine whether to go forward with its recommendations.

Common coding Qs answered

These are the coding questions your colleagues are asking—and the answers from the AOA’s experts could help you.

The heat is on: Ensure patients’ protective eyewear is, too

Some doctors of optometry may see an increase in patients seeking care during the summer months, whether they’re playing sports or battling dry air conditions. Be prepared to share your expertise.